Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 03 Sept 2026 for Kiniksa Pharmaceuticals International, plc. Read the official filing
Filing timeline
BuySaleRoss Moat
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Ross Moat: trading record in brief
All filings by Ross Moat on record concern Kiniksa Pharmaceuticals International, plc, in the capacity of chief executive. Between 15 July 2021 and 1 September 2026, the trades on record add up to 30 filings.
No open-market purchase appears, only 4 sales worth €596k. Outside the open market, there are 10 share grants and 16 option exercises. In 2026 alone, the filings show no purchases and 2 sales.
Most recently, on 3 September 2026, the filings show an option exercise in Kiniksa Pharmaceuticals International, plc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Ross Moat
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations30 total
25 of 30 declarations
